<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cerebral palsy: Epidemiology, etiology, and prevention</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cerebral palsy: Epidemiology, etiology, and prevention</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cerebral palsy: Epidemiology, etiology, and prevention</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth Barkoudah, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bhooma Aravamuthan, MD, DPhil</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marc C Patterson, MD, FRACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 02, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cerebral palsy (CP) refers to a heterogeneous group of conditions involving permanent motor dysfunction that affects muscle tone, posture, and/or movement. These conditions are due to abnormalities of the developing fetal or infant brain resulting from a variety of non-progressive causes. Although the disorder itself is not neurodegenerative, the clinical expression may change over time as the central nervous system matures. The motor impairment results in limitations in functional abilities and activity, which can vary in severity. Multiple additional symptoms often accompany the primary motor abnormalities, including altered sensation or perception, intellectual disability, communication and behavioral difficulties, seizures, and musculoskeletal complications [<a href="#rid1">1</a>].</p><p>The epidemiology, etiology, and prevention of CP are reviewed here. The classification, clinical features, evaluation, diagnosis, management, and prognosis of CP are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6167.html" rel="external">"Cerebral palsy: Classification and clinical features"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6169.html" rel="external">"Cerebral palsy: Evaluation and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6176.html" rel="external">"Cerebral palsy: Overview of management and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118855.html" rel="external">"Cerebral palsy: Treatment of spasticity, dystonia, and associated orthopedic issues"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H338437633"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>The overall prevalence of CP is approximately 2 per 1000 live births in the United States but may be up to 3to 4 per 1000 live births in other parts of the world [<a href="#rid2">2-9</a>]. </p><p>The prevalence of CP is far higher in preterm compared with term infants and increases with decreasing gestational age (GA) and birth weight (BW), as discussed below. (See <a class="local">'Prematurity'</a> below.)</p><p>Although infants born preterm are at higher risk of developing CP, preterm infants account for less than one-half of cases of CP. In large epidemiologic studies of children with CP in high-income countries, approximately 25 percent were very preterm (GA &lt;32 weeks), 10 to 20 percent were moderately preterm or late preterm (GA 32 to 36 weeks), and 60 percent were born at term (GA &gt;36 weeks) [<a href="#rid3">3,10</a>].</p><p>In other parts of the world, postnatal etiologies like infection may be more common causes, perhaps due to reduced survival of children born preterm [<a href="#rid7">7,8</a>]. (See <a class="local">'Specific causes and risk factors'</a> below.)</p><p class="headingAnchor" id="H338437646"><span class="h2">Trends over time</span><span class="headingEndMark"> — </span>In the 1960s through 1980s, the rate of CP and the extent of disability among preterm infants increased as survival improved for the most premature [<a href="#rid11">11</a>]. During the 1980s and 1990s, there was a reversal in this trend, most likely because of improvements in perinatal care. In one study, the prevalence of CP among very low birth weight (VLBW; &lt;1500 g) infants declined from 6 percent in the early 1980s to 4 by the mid-1990s [<a href="#rid12">12</a>]. This improvement occurred despite overall increases in survival and multiple births and decreases in mean BW among this group. In another study, the prevalence of CP among preterm infants (GA 20 to 27 weeks) decreased from 16 percent in the early 1990s to 2 percent by the early 2000s [<a href="#rid13">13</a>]. This was in the setting of stable or decreasing mortality during the same time period.</p><p>Among term and late preterm infants, the prevalence of CP remained stable during the 1980s and 1990s [<a href="#rid14">14</a>]. An analysis of registry data from Europe and Australia found the prevalence of CP declined in infants born from 1995 to 2015, perhaps due to improvements in perinatal care [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3"><span class="h1">SPECIFIC CAUSES AND RISK FACTORS</span><span class="headingEndMark"> — </span>The etiology of CP is often multifactorial and can include anything with a negative impact on the developing fetal or neonatal brain. Numerous antenatal and perinatal risk factors have been reported  (<a class="graphic graphic_table graphicRef102940" href="/z/d/graphic/102940.html" rel="external">table 1</a>), though for many of these risk factors, a causal relationship has not been established [<a href="#rid3">3,10,15-21</a>]. Potentially modifiable prenatal factors that may contribute to CP risk include heavy maternal alcohol consumption, maternal smoking, maternal obesity, and infections during pregnancy [<a href="#rid21">21-28</a>]. Prematurity is the most common association; however, in many cases, no specific cause is identified [<a href="#rid29">29</a>].</p><p>The multifactorial etiology of CP was illustrated in a series of 213 children diagnosed with CP in Australia, of whom 98 percent had contributing causes other than intrapartum hypoxia [<a href="#rid30">30</a>]. The relative frequencies of different contributing factors were as follows (many children had more than one contributing factor):</p><p class="bulletIndent1"><span class="glyph">●</span>Prematurity (78 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Intrauterine growth restriction (34 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Intrauterine infection (28 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Antepartum hemorrhage (27 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Severe placental pathology (21 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple pregnancy (20 percent)</p><p></p><p>In a large case-control study using multivariable logistic regression modeling to identify pre- and perinatal factors associated with increased risk of CP, the strongest independent predictors were 5-minute Apgar score, maternal intrauterine infection, and maternal drug use [<a href="#rid21">21</a>]. Other important predictors included maternal tobacco use, prolonged rupture of membranes, maternal diabetes, preeclampsia, preterm birth, low birthweight, male sex, and history of prior miscarriages. Infants with ≥2 of these risk factors were at substantially higher risk. </p><p>Postnatal events may also be common contributing causes of CP. In a large epidemiological study in Uganda, postnatal causes including cerebral malaria and seizures were attributed to 25 percent of CP cases [<a href="#rid8">8</a>].</p><p>Common causes of CP are described below. The associated causes and risk factors differ somewhat based upon the subtype of CP  (<a class="graphic graphic_table graphicRef74533" href="/z/d/graphic/74533.html" rel="external">table 2</a>) [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H16406295"><span class="h2">Prematurity</span><span class="headingEndMark"> — </span>The prevalence of CP is far higher in preterm compared with term infants. CP develops in approximately 5 to 10 percent of surviving preterm very low birth weight (VLBW; BW &lt;1500 g) infants [<a href="#rid2">2,31</a>]. The risk of CP increases with decreasing gestational age (GA) and birth weight (BW) [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>GA:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>GA &lt;28 weeks – 82 per 1000 live births</p><p class="bulletIndent2"><span class="glyph">•</span>GA 28 to 31 weeks – 43 per 1000 live births</p><p class="bulletIndent2"><span class="glyph">•</span>GA 32 to 36 weeks – 7 per 1000 live births</p><p class="bulletIndent2"><span class="glyph">•</span>GA &gt;36 weeks – 1.4 per 1000 live births</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>BW:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>&lt;1500 g – 59 per 1000 live births</p><p class="bulletIndent2"><span class="glyph">•</span>1500 to 2499 g – 10 per 1000 live births</p><p class="bulletIndent2"><span class="glyph">•</span>&gt;2500 g – 1.3 per 1000 live births</p><p></p><p>In preterm infants, CP is often associated with the following conditions [<a href="#rid32">32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Periventricular leukomalacia (PVL) </strong>– PVL refers to injury of cerebral white matter that occurs in a characteristic distribution affecting white matter tracts responsible for leg motor control more so than tracts controlling the arms. PVL consists of periventricular focal necrosis, with subsequent cystic formation, and more diffuse cerebral white matter injury. PVL is the major form of brain white matter injury that affects premature infants. (See  <a class="medical medical_review" href="/z/d/html/5051.html" rel="external">"Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis", section on 'White matter injury'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraventricular hemorrhage (IVH) </strong>– Severe IVH, periventricular hemorrhagic infarction, and posthemorrhagic hydrocephalus (a potential complication of IVH) may lead to CP [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/z/d/html/5051.html" rel="external">"Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5000.html" rel="external">"Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Management and outcome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchopulmonary dysplasia (BPD)</strong> – The risk of motor impairment is greater in preterm infants affected by BPD [<a href="#rid34">34</a>]. The mechanism is not known but may involve the use of corticosteroids to improve lung disease. This issue is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/5023.html" rel="external">"Postnatal use of glucocorticoids for prevention of bronchopulmonary dysplasia (BPD) in preterm infants"</a> and  <a class="medical medical_review" href="/z/d/html/4977.html" rel="external">"Bronchopulmonary dysplasia (BPD): Management and outcome", section on 'Neurodevelopmental outcomes'</a>.)</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Perinatal hypoxic-ischemic injury</span><span class="headingEndMark"> — </span>Perinatal hypoxia and/or ischemia accounts for a minority of cases of CP [<a href="#rid35">35,36</a>]. Reports of the proportion of CP cases caused by birth asphyxia vary from &lt;3 to &gt;50 percent depending on the definition of birth asphyxia used [<a href="#rid35">35</a>]. In a study using the criteria set forth by the American College of Obstetricians and Gynecologists (ACOG) and the International Cerebral Palsy Task Force  (<a class="graphic graphic_table graphicRef96192" href="/z/d/graphic/96192.html" rel="external">table 3</a>), an acute intrapartum hypoxic event was identified in only 1 percent (2 of 213 infants) of children with CP [<a href="#rid30">30,37</a>]. (See  <a class="medical medical_review" href="/z/d/html/6205.html" rel="external">"Etiology and pathogenesis of neonatal encephalopathy", section on 'Acute events'</a>.)</p><p>When severely damaging perinatal hypoxia occurs, it presents as neonatal encephalopathy, which is a heterogeneous, clinically defined syndrome characterized by disturbed neurologic function in the earliest days of life in an infant born at term, manifested by a subnormal level of consciousness or seizures, often accompanied by difficulty with initiating and maintaining respiration and depression of tone and reflexes [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy"</a>.)</p><p>Neonates with severe intrapartum hypoxia-ischemia may have seizures, encephalopathy, hypotonia, dysfunction of other organ systems, a persistently low Apgar score, and evidence of profound metabolic acidosis. On magnetic resonance imaging (MRI), the two most typical patterns of hypoxic-ischemic injury are basal ganglia/thalamic-predominant pattern and a watershed-predominant pattern  (<a class="graphic graphic_diagnosticimage graphicRef100474" href="/z/d/graphic/100474.html" rel="external">image 1</a>) [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H1022592437"><span class="h2">Antenatal infection or injury</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrauterine infection</strong> – Congenital infections with organisms such as cytomegalovirus, syphilis, Zika virus, varicella virus, and toxoplasmosis are associated with increased risk of CP [<a href="#rid39">39</a>]. Bacterial infections are also associated with CP. (See  <a class="medical medical_review" href="/z/d/html/6011.html" rel="external">"Overview of TORCH infections"</a> and  <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">"Congenital cytomegalovirus infection: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/109681.html" rel="external">"Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate"</a> and  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a>.)</p><p></p><p class="bulletIndent1">Maternal intraamniotic infection (IAI; also called clinical chorioamnionitis) is associated with an increased risk of CP in the offspring [<a href="#rid40">40-43</a>]. A meta-analysis of 12 observational studies demonstrated a strong association between IAI and cerebral palsy (pooled odds ratio [OR] 2.42, 95% CI 1.5-3.8) [<a href="#rid40">40</a>]. Another case-control study found that any maternal infection during pregnancy was associated with increased risk of CP (OR 2.9, 95% CI 1.7-4.8) and that neonatal infection was a strong independent predictor of CP (OR 14.7, 95% CI 1.7-126.5) [<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/z/d/html/6762.html" rel="external">"Clinical chorioamnionitis", section on 'Perinatal outcome'</a>.)</p><p></p><p class="bulletIndent1">In preterm infants, perinatal infection appears to play a key role in the pathogenesis of cystic encephalomalacia, PVL, and subsequent CP [<a href="#rid45">45</a>]. (See <a class="local">'Prematurity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maternal trauma during pregnancy</strong> – Severe trauma during pregnancy can have adverse effects on the developing fetus and may increase the risk of long-term disabilities, including CP. In a population-based longitudinal cohort study that included &gt;2,000,000 children, those with in utero exposure to maternal injury that required emergency department or inpatient care had a higher prevalence of CP compared with unexposed children (3.6 versus 2.5 per 1000 children) [<a href="#rid46">46</a>]. Maternal injuries of greater severity (eg, those resulting in hospitalization) were associated with higher CP risk in the offspring. The association remained statistically significant after adjusting for maternal sociodemographic and clinical characteristics (hazard ratio 1.33, 95% CI 1.18-1.50). These findings highlight the importance of prevention efforts to reduce the risk of severe injury during pregnancy (eg, correct use of seat belts and airbags). (See  <a class="medical medical_review" href="/z/d/html/112420.html" rel="external">"Prenatal care: Patient education, health promotion, and safety of commonly used drugs", section on 'Use of seat belts and air bags'</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Congenital abnormalities</span><span class="headingEndMark"> — </span>Congenital abnormalities, both structural central nervous system (CNS) abnormalities and abnormalities outside of the CNS, are more common in children with than without CP [<a href="#rid15">15,47-51</a>]. Congenital abnormalities are noted in approximately 15 percent of children with CP and are more common in term than preterm infants [<a href="#rid15">15,50</a>]. In one registry study, the most common CNS anomalies were microcephaly and congenital hydrocephalus [<a href="#rid50">50</a>]. Non-CNS anomalies included cardiac, urinary, and skeletal malformations.</p><p>Intrapartum events may be influenced by a preexisting abnormality [<a href="#rid52">52,53</a>]. In one report, congenital anomalies (mostly non-CNS anomalies) occurred more often in term infants with neonatal encephalopathy than in controls (28 versus 4 percent) [<a href="#rid54">54</a>]. The congenital anomaly was considered the cause of the encephalopathy in approximately one-third of affected infants. Infants with congenital anomalies who had encephalopathy were three times more likely to have CP than those without.</p><p>In children with CP due to brain malformations, the biologic basis is usually unknown. Some result from abnormalities that occur during brain development and affect cell proliferation, migration, differentiation, survival, or synaptogenesis. Disorders of development occasionally result from exposure to radiation, toxins, or infectious agents during a critical period of gestation [<a href="#rid55">55-58</a>]. Some disorders (eg, schizencephaly) are genetic and follow Mendelian inheritance patterns [<a href="#rid59">59-63</a>]. Certain cerebral malformations can also be associated with chromosomal abnormalities (eg, holoprosencephaly is associated with both trisomy 13 and 18). Some neurocutaneous syndromes are associated with brain malformations (eg, hemimegalencephaly and hypomelanosis of Ito or the linear sebaceous nevus syndrome) [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/z/d/html/6745.html" rel="external">"Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly", section on 'Schizencephaly'</a> and  <a class="medical medical_review" href="/z/d/html/6745.html" rel="external">"Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly", section on 'Holoprosencephaly'</a> and  <a class="medical medical_review" href="/z/d/html/452.html" rel="external">"Congenital cytogenetic abnormalities", section on 'Trisomy 13 syndrome'</a> and  <a class="medical medical_review" href="/z/d/html/452.html" rel="external">"Congenital cytogenetic abnormalities", section on 'Trisomy 18 syndrome'</a> and  <a class="medical medical_review" href="/z/d/html/3004.html" rel="external">"The genodermatoses: An overview", section on 'Neurocutaneous syndromes'</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Genetic susceptibility</span><span class="headingEndMark"> — </span>A genetic contribution to CP risk was identified by the aggregation of CP in groups with high consanguinity and observations of increased familial risk for CP [<a href="#rid65">65-67</a>]. These disorders were historically thought to be uncommon causes of CP, but with the advent of next-generation genetic testing techniques, they are increasingly recognized as playing an important role in the etiology of CP [<a href="#rid68">68-70</a>]. Genetic factors have been identified in 8 to higher than 30 percent of people with CP [<a href="#rid71">71-77</a>]. In a meta-analysis of 13 studies that included more than 2600 patients with CP who underwent exome or genome testing, the diagnostic yield was 31 percent [<a href="#rid78">78</a>]. In a report of 1345 children with CP (mean age 8.8 years) who were referred for diagnostic exome sequencing at one clinical genetics laboratory, 33 percent were found to have pathogenic or likely pathogenic variants involving &gt;200 distinct genes [<a href="#rid76">76</a>]. The genes most frequently identified were <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F116806&amp;token=87jLzclRwWxNoI%2BQq5Gg76lbRVTEPOMOCAMwvdl8itbMgMur8ee9WQso0E5hmPpg&amp;TOPIC_ID=6173" target="_blank">CTNNB1</a> (n = 18), <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F601255&amp;token=87jLzclRwWxNoI%2BQq5Gg744owjTdojwBA%2BigTK%2FeikQTZs3OCLiMrfwqnVU5so%2FN&amp;TOPIC_ID=6173" target="_blank">KIF1A</a> (n = 8), <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F120130&amp;token=87jLzclRwWxNoI%2BQq5Gg7%2BVnycy1dxmMeBZdgcHOz1VnlgN%2B2mDndGIVvDWjnkxK&amp;TOPIC_ID=6173" target="_blank">COL4A1</a> (n = 7), <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F139311&amp;token=87jLzclRwWxNoI%2BQq5Gg71eBYv87oWllgPzRjsFu5cU%2FIJBrNG0q3WG0k%2BV%2BdUCe&amp;TOPIC_ID=6173" target="_blank">GNAO1</a><em> </em>(n = 7), <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F602235&amp;token=87jLzclRwWxNoI%2BQq5Gg78USUk0hruX1b4gW55R5b1xmxmGgIVZUk%2BKw6IkUW%2BsL&amp;TOPIC_ID=6173" target="_blank">KCNQ2</a> (n = 7), and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F602926&amp;token=87jLzclRwWxNoI%2BQq5Gg74i7UecWRhIq%2BHRTY2rIYnsqYhJnCCAuCwlknFs5TS1D&amp;TOPIC_ID=6173" target="_blank">STXBP1</a> (n = 7). The diagnostic yield was highest when testing was performed concurrently in the proband and both parents (ie, trio testing). Among trios with positive diagnostic results (n = 357), 72 percent had de novo variants, 20 percent were inherited in an autosomal recessive manner, 5 percent were inherited in an autosomal dominant manner, and 3 percent were X-linked.</p><p>Several genetic polymorphisms have been reported to be associated with susceptibility for CP, including apolipoprotein E [<a href="#rid79">79,80</a>], genes associated with thrombophilia (eg, prothrombin <em>G20210A</em> pathologic variant) [<a href="#rid81">81,82</a>], and genes involved with inflammation (eg, inducible nitric oxide synthetase, lymphotoxin alpha, and certain cytokines) [<a href="#rid83">83,84</a>]. However, only the association with prothrombin <em>G20210A</em> pathologic variant was confirmed by a subsequent large study [<a href="#rid82">82</a>]. (See  <a class="medical medical_review" href="/z/d/html/1359.html" rel="external">"Prothrombin G20210A"</a>.)</p><p>However, identifying a genetic cause of CP generally does not replace the diagnosis of CP since some patients with a genetic disorder may have CP due instead or additionally to other causes [<a href="#rid85">85</a>]. Up to 11 percent of those with acquired risk factors for CP have additional genetic findings that may have contributed to their CP phenotype [<a href="#rid68">68,69</a>].</p><p>In addition, numerous genetic disorders can present with findings consistent with CP  (<a class="graphic graphic_table graphicRef102942" href="/z/d/graphic/102942.html" rel="external">table 4</a>). Some inborn errors of metabolism and other progressive disorders may initially mimic CP [<a href="#rid86">86,87</a>]. Genetic testing can sometimes identify these conditions, some of which may be potentially treatable. (See  <a class="medical medical_review" href="/z/d/html/2936.html" rel="external">"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features"</a>.)</p><p>Hereditary spastic paraplegia (HSP), a mimicker of spastic diplegic CP, is a diverse group of neurologic disorders that range in phenotype and inheritance pattern [<a href="#rid88">88,89</a>]. HSP is characterized by progressive lower extremity spasticity; however, progression may be slow, particularly in infantile-onset HSP, making it difficult to distinguish HSP from CP clinically. Corresponding genes that have been linked to HSP are summarized in the table  (<a class="graphic graphic_table graphicRef95449" href="/z/d/graphic/95449.html" rel="external">table 5</a>). HSP is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/14152.html" rel="external">"Hereditary spastic paraplegia"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Multiple births</span><span class="headingEndMark"> — </span>The risk of CP is increased among multiple births [<a href="#rid90">90-95</a>]. Causes that may contribute to this risk include low BW, prematurity, congenital anomalies, cord entanglement, and abnormal vascular connections [<a href="#rid96">96</a>]. In a study of births in Western Australia from 1980 to 1989, the prevalence of CP was 1.6, 7.3, and 28 per 1000 survivors to one year of age in singletons, twins, and triplets, respectively [<a href="#rid90">90</a>]. In this report, the increased rates of CP in multiples were limited to infants of normal BW, although multiples were more likely to have low BW.</p><p>Death of a co-twin greatly increases the risk of CP. In the report from Western Australia, the risk of CP among twins was greater when one twin died in utero (96 versus 12 per 1000 twin pairs) compared with both surviving [<a href="#rid90">90</a>]. The mechanism may include release of thromboplastin and emboli from the dead twin, causing injury to the survivor. It is possible that some cases of CP in apparent singletons may be due to an unrecognized fetal death of a co-twin [<a href="#rid97">97</a>].</p><p>Postnatal death also increases the risk of CP in the surviving co-twin, and monozygosity appears to influence this risk. In a study that analyzed birth and death certificate data (1993 to 1995) for different sex (dizygotic) and same sex (dizygotic and monozygotic) twins, and assessed disability in surviving twins after neonatal death of the co-twin using questionnaires sent to clinicians, the risk of CP was greater in same-sex compared with different-sex twin survivors (167 versus 21 per 1000) for infants of BW 1000 to 1999 g, although the difference was only marginal for infants of BW &lt;1000 g (224 versus 200 per 1000) [<a href="#rid98">98</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Stroke</span><span class="headingEndMark"> — </span>Stroke in the perinatal period contributes to CP, especially unilateral spasticity [<a href="#rid99">99</a>]. Thromboembolism and prothrombotic disorders contribute to the etiology of this disorder. Lesions typically are identified by cranial imaging studies following a neonatal seizure. However, some newborns with stroke appear asymptomatic until hemiparesis or other abnormalities become more apparent as developmental milestones are assessed over time. (See  <a class="medical medical_review" href="/z/d/html/6167.html" rel="external">"Cerebral palsy: Classification and clinical features", section on 'Early signs of cerebral palsy'</a>.)</p><p>Prenatal causes include hypercoagulable states, vasculopathies, abnormal development of blood vessels, and emboli secondary to disorders affecting the placenta or fetus [<a href="#rid100">100</a>]. Stroke that occurs during early infancy may be caused by sepsis, disseminated intravascular coagulation, venous sinus thrombosis, emboli, and congenital heart disease [<a href="#rid101">101,102</a>]. Some cases are caused by periventricular atrophy or cerebral dysgenesis. Affected patients with nondiagnostic neuroimaging may have maldevelopment at a microscopic level [<a href="#rid103">103,104</a>]. However, risk factors for stroke in the neonatal period are unique, and detailed vasculopathy and hypercoagulability evaluations do not predict risk of recurrence [<a href="#rid105">105</a>]. (See  <a class="medical medical_review" href="/z/d/html/6157.html" rel="external">"Stroke in the newborn: Classification, manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Intracranial hemorrhage</span><span class="headingEndMark"> — </span>Intracranial hemorrhage (ICH) in term infants is unusual but frequently results in neuromotor abnormalities. Most are recognized because of the sudden and dramatic onset of symptoms, including seizures, abnormal movements, apnea, lethargy, irritability, vomiting, and bulging fontanelle. Diagnosis is made by cranial imaging.</p><p>The incidence depends in part upon the method of ascertainment. In one series of 33 term infants with symptomatic ICH, the regional incidence was estimated to be 0.27 per 1000 live births [<a href="#rid106">106</a>]. Approximately one-third of cases were related to coagulopathies. In another report, ICH was diagnosed by ultrasound scan in 54 of 2019 term infants (2.7 percent) treated in a newborn intensive care unit from 1989 to 1999 [<a href="#rid107">107</a>]. Neurologic impairment developed in 28 percent.</p><p>Thalamic hemorrhage with residual germinal matrix hemorrhage is a common source of ICH in this population. When no source is apparent, the ICH is thought to originate from the choroid plexus. In one report, thalamic hemorrhage was identified in 12 of 19 term infants younger than one month of age with ICH diagnosed by computed tomography (CT) [<a href="#rid108">108</a>]. Thalamic hemorrhage typically occurred in infants with uneventful birth histories and presentation after one week of age. Many had predisposing factors for cerebral vein thrombosis (eg, sepsis, congenital heart disease, coagulopathy, electrolyte disturbance). At 18 months of age, the majority had CP, predominantly hemiplegia, and other neurologic abnormalities such as hydrocephalus and seizures.</p><p class="headingAnchor" id="H14"><span class="h2">Acquired postnatal causes</span><span class="headingEndMark"> — </span>Though CP in high-income countries is most commonly due to prenatal or perinatal factors, CP can also result from insults to the developing brain acquired during infancy and early childhood, which may be more common causes of CP globally. Approximately 10 to 25 percent of cases of CP are acquired after the neonatal period. Most of these patients have spastic CP. Common causes of postnatally acquired CP include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stroke</strong> − Stroke is uncommon in infants and children and is usually associated with an underlying disorder (eg, congenital heart disease, prothrombotic disorder, sickle cell disease, vasculopathy, or metabolic disorder). Stroke typically results in unilateral spasticity. (See  <a class="medical medical_review" href="/z/d/html/6157.html" rel="external">"Stroke in the newborn: Classification, manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">"Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trauma</strong> − (See  <a class="medical medical_review" href="/z/d/html/6610.html" rel="external">"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe hypoxic events such as near-drowning</strong> − (See  <a class="medical medical_review" href="/z/d/html/180.html" rel="external">"Drowning (submersion injuries)", section on 'Neurologic'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sepsis or meningitis</strong> − (See  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a> and  <a class="medical medical_review" href="/z/d/html/6017.html" rel="external">"Bacterial meningitis in the neonate: Neurologic complications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kernicterus</strong> − Infants with severe hyperbilirubinemia are at risk for kernicterus, permanent neurologic sequelae of bilirubin-induced neurotoxicity that manifests itself as a type of CP characterized by choreoathetosis, with gaze abnormalities and sensorineural hearing loss. The disorder results when unconjugated bilirubin enters the brain and causes focal necrosis of neurons and glia. The regions most often affected include the basal ganglia and the brainstem nuclei for oculomotor and auditory function, accounting for the clinical features of this condition. (See  <a class="medical medical_review" href="/z/d/html/4994.html" rel="external">"Unconjugated hyperbilirubinemia in neonates: Risk factors, clinical manifestations, and neurologic complications", section on 'Chronic bilirubin encephalopathy (kernicterus)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other causes of encephalopathy</strong> − (See  <a class="medical medical_review" href="/z/d/html/6205.html" rel="external">"Etiology and pathogenesis of neonatal encephalopathy"</a> and  <a class="medical medical_review" href="/z/d/html/6154.html" rel="external">"Acute toxic-metabolic encephalopathy in children", section on 'Specific etiologies of encephalopathy'</a>.)</p><p></p><p class="headingAnchor" id="H16"><span class="h1">PREVENTION</span></p><p class="headingAnchor" id="H16405152"><span class="h2">Antenatal measures</span><span class="headingEndMark"> — </span>Antenatal measures to reduce the likelihood of CP include provision of routine prenatal care, including measures to reduce the likelihood of preterm birth. These issues are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/446.html" rel="external">"Prenatal care: Initial assessment"</a> and  <a class="medical medical_review" href="/z/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters"</a> and  <a class="medical medical_review" href="/z/d/html/6761.html" rel="external">"Spontaneous preterm birth: Overview of risk factors and prognosis"</a>.)</p><p class="headingAnchor" id="H16405165"><span class="h2">Magnesium sulfate</span><span class="headingEndMark"> — </span>There is evidence from clinical trials that antenatal administration of <a class="drug drug_pediatric" data-topicid="12982" href="/z/d/drug information/12982.html" rel="external">magnesium sulfate</a> to females at risk for preterm birth decreases the incidence and severity of CP in their offspring without affecting mortality. This issue is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/4481.html" rel="external">"Neuroprotective effects of in utero exposure to magnesium sulfate"</a>.)</p><p class="headingAnchor" id="H4234399981"><span class="h2">Intrapartum measures</span><span class="headingEndMark"> — </span>In vigorous preterm infants, delaying umbilical cord clamping for at least 30 seconds after birth may reduce the risk of intraventricular hemorrhage. This issue is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/134954.html" rel="external">"Labor and delivery: Management of the normal third stage after vaginal birth", section on 'Early versus delayed cord clamping'</a>.)</p><p class="headingAnchor" id="H16405158"><span class="h2">Postnatal measures</span></p><p class="headingAnchor" id="H16405196"><span class="h3">Supportive measures</span><span class="headingEndMark"> — </span>Supportive, neuroprotective measures for neonates at risk of neurologic injury (ie, preterm very low birth weight [VLBW] infants and infants with neonatal asphyxia and/or encephalopathy) are aimed at reducing the likelihood of long-term neurodevelopmental sequelae and include (see  <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy", section on 'Supportive management'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Maintaining adequate ventilation (see  <a class="medical medical_review" href="/z/d/html/5032.html" rel="external">"Overview of mechanical ventilation in neonates"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maintaining sufficient cerebral perfusion (see  <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">"Neonatal shock: Etiology, clinical manifestations, and evaluation"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maintaining normal metabolic status (see  <a class="medical medical_review" href="/z/d/html/5065.html" rel="external">"Fluid and electrolyte therapy in newborns"</a> and  <a class="medical medical_review" href="/z/d/html/101425.html" rel="external">"Management and outcome of neonatal hypoglycemia"</a> and  <a class="medical medical_review" href="/z/d/html/4981.html" rel="external">"Neonatal hyperglycemia", section on 'Management'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Controlling seizures (see  <a class="medical medical_review" href="/z/d/html/6201.html" rel="external">"Treatment of neonatal seizures"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treating any underlying causes for encephalopathy (eg, infection or metabolic derangements) (see  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates"</a> and  <a class="medical medical_review" href="/z/d/html/89456.html" rel="external">"Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation"</a> and  <a class="medical medical_review" href="/z/d/html/2912.html" rel="external">"Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management"</a>)</p><p></p><p class="headingAnchor" id="H16405171"><span class="h3">Therapeutic hypothermia</span><span class="headingEndMark"> — </span>For infants with neonatal asphyxia and/or encephalopathy, therapeutic hypothermia improves survival and neurodevelopmental outcome at 18 months. (See  <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy", section on 'Therapeutic hypothermia'</a>.)</p><p class="headingAnchor" id="H1076247299"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/140087.html" rel="external">"Society guideline links: Cerebral palsy"</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong>– The prevalence of cerebral palsy (CP) is approximately 2 to 3.4 cases per 1000 children. The risk is markedly increased among preterm infants with low birth weight (BW). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology </strong>– The etiology of CP is multifactorial  (<a class="graphic graphic_table graphicRef102940" href="/z/d/graphic/102940.html" rel="external">table 1</a>). In many cases, CP is thought to be due to prenatal factors. (See <a class="local">'Specific causes and risk factors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prematurity and/or low BW are the most commonly identified prenatal risk factors for CP. CP develops in approximately 5 to 15 percent of surviving very low birth weight (VLBW) infants. In this population, CP is often associated with the periventricular leukomalacia (PVL), intraventricular hemorrhage (IVH), and/or bronchopulmonary dysplasia (BPD). (See <a class="local">'Prematurity'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Perinatal hypoxia and/or ischemia likely accounts for a minority of cases of CP. Infants with CP caused by an acute intrapartum hypoxic-ischemic event are more likely to have spastic quadriparesis or dyskinetic CP than other CP subtypes. (See <a class="local">'Perinatal hypoxic-ischemic injury'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intrauterine infections and maternal trauma during pregnancy are risk factors for CP. Congenital infections associated with CP include bacterial infections, cytomegalovirus, syphilis, Zika virus, varicella virus, and toxoplasmosis. (See <a class="local">'Antenatal infection or injury'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Genetic causes may account for up to one-third of all cases of CP. Numerous genetic disorders can present with findings of CP  (<a class="graphic graphic_table graphicRef102942" href="/z/d/graphic/102942.html" rel="external">table 4</a>). (See <a class="local">'Genetic susceptibility'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multiple births are associated with an increased risk of CP due to associated risks of low BW, prematurity, congenital anomalies, cord entanglement, and abnormal vascular connections. (See <a class="local">'Multiple births'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stroke in the perinatal period may cause CP and is typically manifested as unilateral spasticity. (See <a class="local">'Stroke'</a> above and <a class="local">'Intracranial hemorrhage'</a> above and  <a class="medical medical_review" href="/z/d/html/6157.html" rel="external">"Stroke in the newborn: Classification, manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Insults to the developing brain acquired during infancy and early childhood may cause CP. These include stroke, traumatic or hypoxic injury, sepsis, kernicterus, and other sources of encephalopathy in children. (See <a class="local">'Acquired postnatal causes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention </strong>– Preventive measures to reduce the likelihood of CP include (see <a class="local">'Prevention'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antenatal measures </strong>– Provision of routine prenatal care, including measures to reduce the likelihood of preterm birth (see  <a class="medical medical_review" href="/z/d/html/446.html" rel="external">"Prenatal care: Initial assessment"</a> and  <a class="medical medical_review" href="/z/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters"</a> and  <a class="medical medical_review" href="/z/d/html/6761.html" rel="external">"Spontaneous preterm birth: Overview of risk factors and prognosis"</a>)</p><p></p><p class="bulletIndent2">Antenatal administration of <a class="drug drug_pediatric" data-topicid="12982" href="/z/d/drug information/12982.html" rel="external">magnesium sulfate</a> for females at risk for preterm delivery is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4481.html" rel="external">"Neuroprotective effects of in utero exposure to magnesium sulfate"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Intrapartum measures </strong>– In vigorous preterm infants, delaying umbilical cord clamping for at least 30 seconds after birth may reduce the risk of IVH. This issue is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/134954.html" rel="external">"Labor and delivery: Management of the normal third stage after vaginal birth", section on 'Early versus delayed cord clamping'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Postnatal measures </strong>– Supportive neuroprotective measures for neonates at risk of neurologic injury (ie, preterm VLBW infants and infants with neonatal asphyxia and/or encephalopathy) (see  <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy", section on 'Supportive management'</a>)</p><p></p><p class="bulletIndent2">Therapeutic hypothermia for infants with neonatal asphyxia and/or encephalopathy (see  <a class="medical medical_review" href="/z/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy", section on 'Therapeutic hypothermia'</a>)</p><p></p><p class="headingAnchor" id="H2112081475"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Geoffrey Miller, MD and Laurie Glader, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007; 109:8.</a></li><li><a class="nounderline abstract_t">Oskoui M, Coutinho F, Dykeman J, et al. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol 2013; 55:509.</a></li><li><a class="nounderline abstract_t">Hirvonen M, Ojala R, Korhonen P, et al. Cerebral palsy among children born moderately and late preterm. Pediatrics 2014; 134:e1584.</a></li><li><a class="nounderline abstract_t">Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology 2007; 68:326.</a></li><li><a class="nounderline abstract_t">Sellier E, Platt MJ, Andersen GL, et al. Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol 2016; 58:85.</a></li><li><a class="nounderline abstract_t">Van Naarden Braun K, Doernberg N, Schieve L, et al. Birth Prevalence of Cerebral Palsy: A Population-Based Study. Pediatrics 2016; 137.</a></li><li><a class="nounderline abstract_t">Jahan I, Muhit M, Hardianto D, et al. Epidemiology of cerebral palsy in low- and middle-income countries: preliminary findings from an international multi-centre cerebral palsy register. Dev Med Child Neurol 2021; 63:1327.</a></li><li><a class="nounderline abstract_t">Kakooza-Mwesige A, Andrews C, Peterson S, et al. Prevalence of cerebral palsy in Uganda: a population-based study. Lancet Glob Health 2017; 5:e1275.</a></li><li><a class="nounderline abstract_t">McIntyre S, Goldsmith S, Webb A, et al. Global prevalence of cerebral palsy: A systematic analysis. Dev Med Child Neurol 2022; 64:1494.</a></li><li><a class="nounderline abstract_t">Hjern A, Thorngren-Jerneck K. Perinatal complications and socio-economic differences in cerebral palsy in Sweden - a national cohort study. BMC Pediatr 2008; 8:49.</a></li><li><a class="nounderline abstract_t">Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 1996; 75:F169.</a></li><li><a class="nounderline abstract_t">Platt MJ, Cans C, Johnson A, et al. Trends in cerebral palsy among infants of very low birthweight (&lt;1500 g) or born prematurely (&lt;32 weeks) in 16 European centres: a database study. Lancet 2007; 369:43.</a></li><li><a class="nounderline abstract_t">Robertson CM, Watt MJ, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 2007; 297:2733.</a></li><li><a class="nounderline abstract_t">Nelson KB. The epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev 2002; 8:146.</a></li><li><a class="nounderline abstract_t">Croen LA, Grether JK, Curry CJ, Nelson KB. Congenital abnormalities among children with cerebral palsy: More evidence for prenatal antecedents. J Pediatr 2001; 138:804.</a></li><li><a class="nounderline abstract_t">Pharoah PO, Cooke T, Rosenbloom L. Acquired cerebral palsy. Arch Dis Child 1989; 64:1013.</a></li><li><a class="nounderline abstract_t">Himmelmann K, Ahlin K, Jacobsson B, et al. Risk factors for cerebral palsy in children born at term. Acta Obstet Gynecol Scand 2011; 90:1070.</a></li><li><a class="nounderline abstract_t">Thygesen SK, Olsen M, Østergaard JR, Sørensen HT. Respiratory distress syndrome in moderately late and late preterm infants and risk of cerebral palsy: a population-based cohort study. BMJ Open 2016; 6:e011643.</a></li><li><a class="nounderline abstract_t">Persson M, Razaz N, Tedroff K, et al. Five and 10 minute Apgar scores and risks of cerebral palsy and epilepsy: population based cohort study in Sweden. BMJ 2018.</a></li><li><a class="nounderline abstract_t">Metz C, Jaster M, Walch E, et al. Clinical Phenotype of Cerebral Palsy Depends on the Cause: Is It Really Cerebral Palsy? A Retrospective Study. J Child Neurol 2022; 37:112.</a></li><li><a class="nounderline abstract_t">Rouabhi A, Husein N, Dewey D, et al. Development of a Bedside Tool to Predict the Diagnosis of Cerebral Palsy in Term-Born Neonates. JAMA Pediatr 2023; 177:177.</a></li><li><a class="nounderline abstract_t">Forthun I, Wilcox AJ, Strandberg-Larsen K, et al. Maternal Prepregnancy BMI and Risk of Cerebral Palsy in Offspring. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">O'Leary CM, Watson L, D'Antoine H, et al. Heavy maternal alcohol consumption and cerebral palsy in the offspring. Dev Med Child Neurol 2012; 54:224.</a></li><li><a class="nounderline abstract_t">Abel EL. Cerebral palsy and alcohol consumption during pregnancy: is there a connection? Alcohol Alcohol 2010; 45:592.</a></li><li><a class="nounderline abstract_t">Streja E, Miller JE, Bech BH, et al. Congenital cerebral palsy and prenatal exposure to self-reported maternal infections, fever, or smoking. Am J Obstet Gynecol 2013; 209:332.e1.</a></li><li><a class="nounderline abstract_t">Villamor E, Tedroff K, Peterson M, et al. Association Between Maternal Body Mass Index in Early Pregnancy and Incidence of Cerebral Palsy. JAMA 2017; 317:925.</a></li><li><a class="nounderline abstract_t">Ayubi E, Sarhadi S, Mansori K. Maternal Infection During Pregnancy and Risk of Cerebral Palsy in Children: A Systematic Review and Meta-analysis. J Child Neurol 2021; 36:385.</a></li><li><a class="nounderline abstract_t">Strøm MS, Tollånes MC, Wilcox AJ, et al. Maternal Chronic Conditions and Risk of Cerebral Palsy in Offspring: A National Cohort Study. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Nelson KB. Can we prevent cerebral palsy? N Engl J Med 2003; 349:1765.</a></li><li><a class="nounderline abstract_t">Strijbis EM, Oudman I, van Essen P, MacLennan AH. Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstet Gynecol 2006; 107:1357.</a></li><li><a class="nounderline abstract_t">Hafström M, Källén K, Serenius F, et al. Cerebral Palsy in Extremely Preterm Infants. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Linsell L, Malouf R, Morris J, et al. Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review. Dev Med Child Neurol 2016; 58:554.</a></li><li><a class="nounderline abstract_t">Dykes FD, Dunbar B, Lazarra A, Ahmann PA. Posthemorrhagic hydrocephalus in high-risk preterm infants: natural history, management, and long-term outcome. J Pediatr 1989; 114:611.</a></li><li><a class="nounderline abstract_t">Gou X, Yang L, Pan L, Xiao D. Association between bronchopulmonary dysplasia and cerebral palsy in children: a meta-analysis. BMJ Open 2018; 8:e020735.</a></li><li><a class="nounderline abstract_t">Ellenberg JH, Nelson KB. The association of cerebral palsy with birth asphyxia: a definitional quagmire. Dev Med Child Neurol 2013; 55:210.</a></li><li><a class="nounderline abstract_t">McIntyre S, Blair E, Badawi N, et al. Antecedents of cerebral palsy and perinatal death in term and late preterm singletons. Obstet Gynecol 2013; 122:869.</a></li><li><a class="nounderline abstract_t">Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy. Obstet Gynecol 2014; 123:896. Reaffirmed 2020.</a></li><li><a class="nounderline abstract_t">de Vries LS, Groenendaal F. Patterns of neonatal hypoxic-ischaemic brain injury. Neuroradiology 2010; 52:555.</a></li><li><a class="nounderline abstract_t">Sameshima H, Ikenoue T. Developmental effects on neonatal mortality and subsequent cerebral palsy in infants exposed to intrauterine infection. Early Hum Dev 2007; 83:517.</a></li><li><a class="nounderline abstract_t">Shatrov JG, Birch SC, Lam LT, et al. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol 2010; 116:387.</a></li><li><a class="nounderline abstract_t">Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278:207.</a></li><li><a class="nounderline abstract_t">Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I. Univariate analysis of risks. Am J Dis Child 1985; 139:1031.</a></li><li><a class="nounderline abstract_t">Wu YW, Escobar GJ, Grether JK, et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003; 290:2677.</a></li><li><a class="nounderline abstract_t">Ahlin K, Himmelmann K, Hagberg G, et al. Cerebral palsy and perinatal infection in children born at term. Obstet Gynecol 2013; 122:41.</a></li><li><a class="nounderline abstract_t">O'Shea TM. Cerebral palsy in very preterm infants: new epidemiological insights. Ment Retard Dev Disabil Res Rev 2002; 8:135.</a></li><li><a class="nounderline abstract_t">Ahmed A, Rosella LC, Oskoui M, et al. In Utero Exposure to Maternal Injury and the Associated Risk of Cerebral Palsy. JAMA Pediatr 2023; 177:53.</a></li><li><a class="nounderline abstract_t">Pharoah PO. Prevalence and pathogenesis of congenital anomalies in cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2007; 92:F489.</a></li><li><a class="nounderline abstract_t">Garne E, Dolk H, Krägeloh-Mann I, et al. Cerebral palsy and congenital malformations. Eur J Paediatr Neurol 2008; 12:82.</a></li><li><a class="nounderline abstract_t">Wu YW, Croen LA, Shah SJ, et al. Cerebral palsy in a term population: risk factors and neuroimaging findings. Pediatrics 2006; 118:690.</a></li><li><a class="nounderline abstract_t">Rankin J, Cans C, Garne E, et al. Congenital anomalies in children with cerebral palsy: a population-based record linkage study. Dev Med Child Neurol 2010; 52:345.</a></li><li><a class="nounderline abstract_t">Goldsmith S, McIntyre S, Hansen M, Badawi N. Congenital Anomalies in Children With Cerebral Palsy: A Systematic Review. J Child Neurol 2019; 34:720.</a></li><li><a class="nounderline abstract_t">Freeman JM, Nelson KB. Intrapartum asphyxia and cerebral palsy. Pediatrics 1988; 82:240.</a></li><li class="breakAll">Brann AW. Factors during neonatal life that influence brain disorder. In: Prenatal and Perinatal Factors Associated with Brain Disorders (NIH Pub. No. 85-1149), Freeman JM (Ed), US Government Printing Office, Washington, DC 1998. p.263.</li><li><a class="nounderline abstract_t">Felix JF, Badawi N, Kurinczuk JJ, et al. Birth defects in children with newborn encephalopathy. Dev Med Child Neurol 2000; 42:803.</a></li><li><a class="nounderline abstract_t">Wood JW, Johnson KG, Omori Y. In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later. Pediatrics 1967; 39:385.</a></li><li><a class="nounderline abstract_t">Dekaban AS. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I. J Nucl Med 1968; 9:471.</a></li><li><a class="nounderline abstract_t">Brent RL, Beckman DA. Environmental teratogens. Bull N Y Acad Med 1990; 66:123.</a></li><li><a class="nounderline abstract_t">Rorke LB. A perspective: the role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J Neuropathol Exp Neurol 1994; 53:105.</a></li><li><a class="nounderline abstract_t">Hilburger AC, Willis JK, Bouldin E, Henderson-Tilton A. Familial schizencephaly. Brain Dev 1993; 15:234.</a></li><li><a class="nounderline abstract_t">Haverkamp F, Zerres K, Ostertun B, et al. Familial schizencephaly: further delineation of a rare disorder. J Med Genet 1995; 32:242.</a></li><li><a class="nounderline abstract_t">Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996; 14:357.</a></li><li><a class="nounderline abstract_t">Dobyns WB, Andermann E, Andermann F, et al. X-linked malformations of neuronal migration. Neurology 1996; 47:331.</a></li><li><a class="nounderline abstract_t">Barkovich AJ, Kuzniecky RI, Dobyns WB, et al. A classification scheme for malformations of cortical development. Neuropediatrics 1996; 27:59.</a></li><li><a class="nounderline abstract_t">Dodge NN, Dobyns WB. Agenesis of the corpus callosum and Dandy-Walker malformation associated with hemimegalencephaly in the sebaceous nevus syndrome. Am J Med Genet 1995; 56:147.</a></li><li><a class="nounderline abstract_t">Bundey S, Griffiths MI. Recurrence risks in families of children with symmetrical spasticity. Dev Med Child Neurol 1977; 19:179.</a></li><li><a class="nounderline abstract_t">Hemminki K, Sundquist K, Li X. Familial risks for main neurological diseases in siblings based on hospitalizations in Sweden. Twin Res Hum Genet 2006; 9:580.</a></li><li><a class="nounderline abstract_t">Tollånes MC, Wilcox AJ, Lie RT, Moster D. Familial risk of cerebral palsy: population based cohort study. BMJ 2014; 349:g4294.</a></li><li><a class="nounderline abstract_t">Chopra M, Gable DL, Love-Nichols J, et al. Mendelian etiologies identified with whole exome sequencing in cerebral palsy. Ann Clin Transl Neurol 2022; 9:193.</a></li><li><a class="nounderline abstract_t">May HJ, Fasheun JA, Bain JM, et al. Genetic testing in individuals with cerebral palsy. Dev Med Child Neurol 2021; 63:1448.</a></li><li><a class="nounderline abstract_t">Jin SC, Lewis SA, Bakhtiari S, et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat Genet 2020; 52:1046.</a></li><li><a class="nounderline abstract_t">Schaefer GB. Genetics considerations in cerebral palsy. Semin Pediatr Neurol 2008; 15:21.</a></li><li><a class="nounderline abstract_t">Moreno-De-Luca A, Ledbetter DH, Martin CL. Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies. Lancet Neurol 2012; 11:283.</a></li><li><a class="nounderline abstract_t">MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol 2015; 213:779.</a></li><li><a class="nounderline abstract_t">McMichael G, Bainbridge MN, Haan E, et al. Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry 2015; 20:176.</a></li><li><a class="nounderline abstract_t">Segel R, Ben-Pazi H, Zeligson S, et al. Copy number variations in cryptogenic cerebral palsy. Neurology 2015; 84:1660.</a></li><li><a class="nounderline abstract_t">Moreno-De-Luca A, Millan F, Pesacreta DR, et al. Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy. JAMA 2021; 325:467.</a></li><li><a class="nounderline abstract_t">Fahey MC, Maclennan AH, Kretzschmar D, et al. The genetic basis of cerebral palsy. Dev Med Child Neurol 2017; 59:462.</a></li><li><a class="nounderline abstract_t">Gonzalez-Mantilla PJ, Hu Y, Myers SM, et al. Diagnostic Yield of Exome Sequencing in Cerebral Palsy and Implications for Genetic Testing Guidelines: A Systematic Review and Meta-analysis. JAMA Pediatr 2023; 177:472.</a></li><li><a class="nounderline abstract_t">Kuroda MM, Weck ME, Sarwark JF, et al. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007; 119:306.</a></li><li><a class="nounderline abstract_t">Lien E, Andersen G, Bao Y, et al. Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E. Acta Paediatr 2015; 104:701.</a></li><li><a class="nounderline abstract_t">Gibson CS, MacLennan AH, Hague WM, et al. Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol 2005; 193:1437.</a></li><li><a class="nounderline abstract_t">O'Callaghan ME, Maclennan AH, Gibson CS, et al. Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study. Pediatrics 2012; 129:e414.</a></li><li><a class="nounderline abstract_t">Gibson CS, MacLennan AH, Goldwater PN, et al. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194:674.e1.</a></li><li><a class="nounderline abstract_t">Gibson CS, Maclennan AH, Dekker GA, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008; 122:1079.</a></li><li><a class="nounderline abstract_t">MacLennan AH, Lewis S, Moreno-De-Luca A, et al. Genetic or Other Causation Should Not Change the Clinical Diagnosis of Cerebral Palsy. J Child Neurol 2019; 34:472.</a></li><li><a class="nounderline abstract_t">Leach EL, Shevell M, Bowden K, et al. Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review. Orphanet J Rare Dis 2014; 9:197.</a></li><li><a class="nounderline abstract_t">Hakami WS, Hundallah KJ, Tabarki BM. Metabolic and genetic disorders mimicking cerebral palsy. Neurosciences (Riyadh) 2019; 24:155.</a></li><li><a class="nounderline abstract_t">Parodi L, Fenu S, Stevanin G, Durr A. Hereditary spastic paraplegia: More than an upper motor neuron disease. Rev Neurol (Paris) 2017; 173:352.</a></li><li><a class="nounderline abstract_t">Schüle R, Wiethoff S, Martus P, et al. Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients. Ann Neurol 2016; 79:646.</a></li><li><a class="nounderline abstract_t">Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ 1993; 307:1239.</a></li><li><a class="nounderline abstract_t">Pharoah PO, Cooke T. Cerebral palsy and multiple births. Arch Dis Child Fetal Neonatal Ed 1996; 75:F174.</a></li><li><a class="nounderline abstract_t">Scheller JM, Nelson KB. Twinning and neurologic morbidity. Am J Dis Child 1992; 146:1110.</a></li><li><a class="nounderline abstract_t">Weig SG, Marshall PC, Abroms IF, Gauthier NS. Patterns of cerebral injury and clinical presentation in the vascular disruptive syndrome of monozygotic twins. Pediatr Neurol 1995; 13:279.</a></li><li><a class="nounderline abstract_t">Bonellie SR, Currie D, Chalmers J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol 2005; 47:587.</a></li><li><a class="nounderline abstract_t">Topp M, Huusom LD, Langhoff-Roos J, et al. Multiple birth and cerebral palsy in Europe: a multicenter study. Acta Obstet Gynecol Scand 2004; 83:548.</a></li><li><a class="nounderline abstract_t">Bejar R, Vigliocco G, Gramajo H, et al. Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol 1990; 162:1230.</a></li><li><a class="nounderline abstract_t">Pharoah PO. Twins and cerebral palsy. Acta Paediatr Suppl 2001; 90:6.</a></li><li><a class="nounderline abstract_t">Pharoah PO. Cerebral palsy in the surviving twin associated with infant death of the co-twin. Arch Dis Child Fetal Neonatal Ed 2001; 84:F111.</a></li><li><a class="nounderline abstract_t">Dunbar M, Kirton A. Perinatal stroke: mechanisms, management, and outcomes of early cerebrovascular brain injury. Lancet Child Adolesc Health 2018; 2:666.</a></li><li><a class="nounderline abstract_t">Nelson KB. Prenatal origin of hemiparetic cerebral palsy: how often and why? Pediatrics 1991; 88:1059.</a></li><li><a class="nounderline abstract_t">Barmada MA, Moossy J, Shuman RM. Cerebral infarcts with arterial occlusion in neonates. Ann Neurol 1979; 6:495.</a></li><li><a class="nounderline abstract_t">Levy SR, Abroms IF, Marshall PC, Rosquete EE. Seizures and cerebral infarction in the full-term newborn. Ann Neurol 1985; 17:366.</a></li><li><a class="nounderline abstract_t">Wiklund LM, Uvebrant P. Hemiplegic cerebral palsy: correlation between CT morphology and clinical findings. Dev Med Child Neurol 1991; 33:512.</a></li><li><a class="nounderline abstract_t">Kuban KC, Leviton A. Cerebral palsy. N Engl J Med 1994; 330:188.</a></li><li><a class="nounderline abstract_t">Lehman LL, Beaute J, Kapur K, et al. Workup for Perinatal Stroke Does Not Predict Recurrence. Stroke 2017; 48:2078.</a></li><li><a class="nounderline abstract_t">Hanigan WC, Powell FC, Miller TC, Wright RM. Symptomatic intracranial hemorrhage in full-term infants. Childs Nerv Syst 1995; 11:698.</a></li><li><a class="nounderline abstract_t">Gradnitzer E, Urlesberger B, Maurer U, et al. [Cerebral hemorrhage in term newborn infants--an analysis of 10 years (1989-1999)]. Wien Med Wochenschr 2002; 152:9.</a></li><li><a class="nounderline abstract_t">Roland EH, Flodmark O, Hill A. Thalamic hemorrhage with intraventricular hemorrhage in the full-term newborn. Pediatrics 1990; 85:737.</a></li></ol></div><div id="topicVersionRevision">Topic 6173 Version 55.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17370477" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A report: the definition and classification of cerebral palsy April 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23346889" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : An update on the prevalence of cerebral palsy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25422011" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Cerebral palsy among children born moderately and late preterm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17261678" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : How common are the "common" neurologic disorders?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26330098" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26659459" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Birth Prevalence of Cerebral Palsy: A Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34031872" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Epidemiology of cerebral palsy in low- and middle-income countries: preliminary findings from an international multi-centre cerebral palsy register.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29102350" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prevalence of cerebral palsy in Uganda: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35952356" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Global prevalence of cerebral palsy: A systematic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18973666" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Perinatal complications and socio-economic differences in cerebral palsy in Sweden - a national cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8976681" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The changing epidemiology of cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17208641" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Trends in cerebral palsy among infants of very low birthweight (&lt;1500 g) or born prematurely (&lt;32 weeks) in 16 European centres: a database study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17595274" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12216058" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The epidemiology of cerebral palsy in term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11391320" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Congenital abnormalities among children with cerebral palsy: More evidence for prenatal antecedents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2629622" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Acquired cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21682697" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Risk factors for cerebral palsy in children born at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27729347" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Respiratory distress syndrome in moderately late and late preterm infants and risk of cerebral palsy: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Five and 10 minute Apgar scores and risks of cerebral palsy and epilepsy: population based cohort study in Sweden</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34898314" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Clinical Phenotype of Cerebral Palsy Depends on the Cause: Is It Really Cerebral Palsy? A Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36648921" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Development of a Bedside Tool to Predict the Diagnosis of Cerebral Palsy in Term-Born Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27609826" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Maternal Prepregnancy BMI and Risk of Cerebral Palsy in Offspring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22268559" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Heavy maternal alcohol consumption and cerebral palsy in the offspring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20880958" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cerebral palsy and alcohol consumption during pregnancy: is there a connection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23791566" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Congenital cerebral palsy and prenatal exposure to self-reported maternal infections, fever, or smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28267854" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Association Between Maternal Body Mass Index in Early Pregnancy and Incidence of Cerebral Palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33231118" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Maternal Infection During Pregnancy and Risk of Cerebral Palsy in Children: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33602799" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Maternal Chronic Conditions and Risk of Cerebral Palsy in Offspring: A National Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14585946" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Can we prevent cerebral palsy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16738164" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29222398" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cerebral Palsy in Extremely Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26862030" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2926574" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Posthemorrhagic hydrocephalus in high-risk preterm infants: natural history, management, and long-term outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30232102" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Association between bronchopulmonary dysplasia and cerebral palsy in children: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23121164" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The association of cerebral palsy with birth asphyxia: a definitional quagmire.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24084547" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Antecedents of cerebral palsy and perinatal death in term and late preterm singletons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24785633" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20390260" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Patterns of neonatal hypoxic-ischaemic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17196773" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Developmental effects on neonatal mortality and subsequent cerebral palsy in infants exposed to intrauterine infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664400" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Chorioamnionitis and cerebral palsy: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9218666" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Maternal infection and cerebral palsy in infants of normal birth weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4036890" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Antecedents of cerebral palsy. I. Univariate analysis of risks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14645309" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Chorioamnionitis and cerebral palsy in term and near-term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23743468" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Cerebral palsy and perinatal infection in children born at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12216057" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cerebral palsy in very preterm infants: new epidemiological insights.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36441546" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : In Utero Exposure to Maternal Injury and the Associated Risk of Cerebral Palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17428819" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prevalence and pathogenesis of congenital anomalies in cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17881257" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Cerebral palsy and congenital malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16882824" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Cerebral palsy in a term population: risk factors and neuroimaging findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19737295" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Congenital anomalies in children with cerebral palsy: a population-based record linkage study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31208251" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Congenital Anomalies in Children With Cerebral Palsy: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3041363" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Intrapartum asphyxia and cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3041363" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Intrapartum asphyxia and cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11132253" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Birth defects in children with newborn encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6066886" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5747864" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2194610" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Environmental teratogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8120535" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A perspective: the role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8214352" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Familial schizencephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7783181" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Familial schizencephaly: further delineation of a rare disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8896572" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Mutations in the human Sonic Hedgehog gene cause holoprosencephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8757001" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : X-linked malformations of neuronal migration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8737819" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A classification scheme for malformations of cortical development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7625436" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Agenesis of the corpus callosum and Dandy-Walker malformation associated with hemimegalencephaly in the sebaceous nevus syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/870357" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Recurrence risks in families of children with symmetrical spasticity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16899166" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Familial risks for main neurological diseases in siblings based on hospitalizations in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25028249" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Familial risk of cerebral palsy: population based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35076175" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Mendelian etiologies identified with whole exome sequencing in cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34114234" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Genetic testing in individuals with cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32989326" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18342257" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Genetics considerations in cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22261432" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Genetic [corrected] insights into the causes and classification of [corrected]cerebral palsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26003063" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Cerebral palsy: causes, pathways, and the role of genetic variants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25666757" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25817843" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Copy number variations in cryptogenic cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33528536" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28042670" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The genetic basis of cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36877506" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Diagnostic Yield of Exome Sequencing in Cerebral Palsy and Implications for Genetic Testing Guidelines: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17272620" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Association of apolipoprotein E genotype and cerebral palsy in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25703783" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16202738" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Associations between inherited thrombophilias, gestational age, and cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22291124" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16522396" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The association between inherited cytokine polymorphisms and cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18977990" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Candidate genes and cerebral palsy: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30963790" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Genetic or Other Causation Should Not Change the Clinical Diagnosis of Cerebral Palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25433678" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31380813" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Metabolic and genetic disorders mimicking cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28449883" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Hereditary spastic paraplegia: More than an upper motor neuron disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26856398" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8281055" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8976682" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Cerebral palsy and multiple births.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1514562" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Twinning and neurologic morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8771162" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Patterns of cerebral injury and clinical presentation in the vascular disruptive syndrome of monozygotic twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16138664" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Comparison of risk factors for cerebral palsy in twins and singletons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15144336" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Multiple birth and cerebral palsy in Europe: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2187353" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11332955" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Twins and cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11207227" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Cerebral palsy in the surviving twin associated with infant death of the co-twin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30119760" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Perinatal stroke: mechanisms, management, and outcomes of early cerebrovascular brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1945614" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Prenatal origin of hemiparetic cerebral palsy: how often and why?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/533248" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Cerebral infarcts with arterial occlusion in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4004159" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Seizures and cerebral infarction in the full-term newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1864477" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Hemiplegic cerebral palsy: correlation between CT morphology and clinical findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8264743" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28706112" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Workup for Perinatal Stroke Does Not Predict Recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8750952" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Symptomatic intracranial hemorrhage in full-term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11862688" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : [Cerebral hemorrhage in term newborn infants--an analysis of 10 years (1989-1999)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2330233" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Thalamic hemorrhage with intraventricular hemorrhage in the full-term newborn.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
